149 related items for PubMed ID: 9893457
21. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
22. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
Norero C, Delucchi A, Lagos E, Rosati P.
Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
[Abstract] [Full Text] [Related]
23. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
24. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug 23; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
25. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan 23; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
26. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM.
J Nephrol; 1997 Jan 23; 10(5):266-70. PubMed ID: 9364319
[Abstract] [Full Text] [Related]
27. Steroid sensitive nephrotic syndrome in paediatrics.
Nadir SJ, Saleem N, Amin F, Mahmood KT.
Pak J Pharm Sci; 2011 Apr 23; 24(2):207-10. PubMed ID: 21454171
[Abstract] [Full Text] [Related]
28. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct 23; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
29. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF.
Am J Kidney Dis; 2007 May 23; 49(5):592-7. PubMed ID: 17472840
[Abstract] [Full Text] [Related]
30. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F, Ahmed TM, Samina U.
J Coll Physicians Surg Pak; 2006 Jan 23; 16(1):35-7. PubMed ID: 16441986
[Abstract] [Full Text] [Related]
31. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK, Bagga A, Srivastava RN.
Pediatr Nephrol; 1997 Oct 23; 11(5):597-9. PubMed ID: 9323286
[Abstract] [Full Text] [Related]
32. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
Nephrol Dial Transplant; 1993 Oct 23; 8(12):1326-32. PubMed ID: 8159300
[Abstract] [Full Text] [Related]
33. Acupuncture in patients with carpal tunnel syndrome: A randomized controlled trial.
Yang CP, Hsieh CL, Wang NH, Li TC, Hwang KL, Yu SC, Chang MH.
Clin J Pain; 2009 May 23; 25(4):327-33. PubMed ID: 19590482
[Abstract] [Full Text] [Related]
34. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J, Grundy N, Trompeter R, Tullus K.
Arch Dis Child; 2010 Feb 23; 95(2):146-9. PubMed ID: 20172895
[Abstract] [Full Text] [Related]
35. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May 23; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
36. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.
Arthritis Rheum; 2005 Aug 23; 52(8):2461-9. PubMed ID: 16052573
[Abstract] [Full Text] [Related]
37. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Aug 23; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
38. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR, Vijaykumar M, Prahlad N, Jain DV.
Indian Pediatr; 2006 Jan 23; 43(1):39-43. PubMed ID: 16465005
[Abstract] [Full Text] [Related]
39. The treatment of relapsing primary nephrotic syndrome in children.
Wang YP, Liu AM, Dai YW, Yang C, Tang HF.
J Zhejiang Univ Sci B; 2005 Jul 23; 6(7):682-5. PubMed ID: 15973773
[Abstract] [Full Text] [Related]
40. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 23; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
